We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Basalioma of the eyelid: rate and factors of recurrence after surgical therapy].
Ceská a Slovenská Oftalmologie 2010 October
UNLABELLED: The aim of our study was to evaluate a recurrence rate of basalioma of the eyelid after surgical therapy. In our cohort of patients we also assessed a relation between the recurrence and chosen clinical parameters (localisation and size of tumour, TNM classification, histopathological grade of differentiation, margins of excision).
MATERIAL AND METHODS: Retrospective analysis of data from patients with basalioma of the eyelid treated surgically at the Department of Ophthalmology, Faculty of Medicine Comenius University in Bratislava during the years 2005-2007. The excision exceeded the macroscopically visible margins of tumor with a safety margin of 2-3 mm into the healthy tissue.
RESULTS: In our cohort we studied 67 histologically proven tumors in 65 patients. During a mean follow-up time of 24.6 +/- 13.6 months we found a recurrence in 4 tumors (6,0%), one of them subsequently recidivated for a second time. There was no statistically significant relation between the studied parameters and a tumor recurrence.
CONCLUSION: Our recurrence rate of 6.0% is comparable with the published results from other centers.
MATERIAL AND METHODS: Retrospective analysis of data from patients with basalioma of the eyelid treated surgically at the Department of Ophthalmology, Faculty of Medicine Comenius University in Bratislava during the years 2005-2007. The excision exceeded the macroscopically visible margins of tumor with a safety margin of 2-3 mm into the healthy tissue.
RESULTS: In our cohort we studied 67 histologically proven tumors in 65 patients. During a mean follow-up time of 24.6 +/- 13.6 months we found a recurrence in 4 tumors (6,0%), one of them subsequently recidivated for a second time. There was no statistically significant relation between the studied parameters and a tumor recurrence.
CONCLUSION: Our recurrence rate of 6.0% is comparable with the published results from other centers.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app